Harm reduction and the global drug control regime: contemporary problems and future prospects.
Countries committed to a harm-reduction approach to drugs have exploited the latitude which exists within the UN global drug control regime to implement strategies which deviate from the strict prohibition ethos of the conventions. These nations risk pressure being brought to bear through the UN drug control regime, principally by the United States, determined to prevent what it sees as foreign challenges to its domestic 'zero tolerance' approach and its internationalisation. In this paper, based on his presentation to the International Conference on the Reduction of Drug Related Harm in Melbourne this year, David Bewley-Taylor, describes the conventions and the 'wiggle room' which exists, but also imagines ways like-minded states might together challenge and reform the conventions so that harm reduction can be accepted and hard wired into the UN drug control system itself.
Bewley-Taylor
David R
DR
University of Wales Swansea, Swansea, UK. d.r.taylor@swansea.ac.uk
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000635:transmission; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D040261:Harm Reduction; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D013287:Illicit Drugs; D007391:International Cooperation; D009293:Opioid-Related Disorders / Q000453:epidemiology / Q000517:prevention & control*; D011209:Power, Psychological; D011619:Psychotropic Drugs; D012959:Socioeconomic Factors; D015819:Substance Abuse, Intravenous / Q000453:epidemiology / Q000517:prevention & control; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000517:prevention & control*; D014480:United Nations / Q000331:legislation & jurisprudence*; D014481:United States
D013287:Illicit Drugs; D011619:Psychotropic Drugs